AZN vs CBL · P/E 28, $288.38B cap vs P/E 8.6, rev $292.4M
AstraZeneca PLC (AZN) versus CBL & Associates Properties Inc (CBL) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
CBL & Associates Properties Inc (CBL) is a reit - retail company listed on NYSE.
AZN does not have a complete income-statement cache yet.
Latest reported CBL revenue for 2026-06-30 was $292.4M. Net income was $92.9M. CBL currently screens at market cap $1.48B and trailing P/E 8.6.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. CBL currently screens at market cap $1.48B and trailing P/E 8.6.
Not investment advice. Open the AZN and CBL stock pages for the full models.
Not investment advice.